MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy by Vojtech Petr, Vojtech Petr, Dorottya Csuka, Petra Hruba, Ágnes Szilágyi, Marek Kollar, Antonij Slavcev, Zoltán Prohászka, Ondrej Viklicky, Ondrej Viklicky

Get full text

Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine by Ivan Zahradka, Vojtech Petr, Katarina Jakubov, Istvan Modos, Filip Hruby, Ondrej Viklicky, Ondrej Viklicky

Get full text

Acute Kidney Injury in Deceased Organ Donors: Risk Factors And Impacts on Transplantation Outcomes by Katarina Jakubov, MD, Vojtech Petr, MD, Ivan Zahradka, MD, Eva Girmanova, MSc, Petra Hruba, PhD, Roman Keleman, MSc, Ondrej Viklicky, MD, PhD

Get full text

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study by Vojtech Petr, MD, Ivan Zahradka, MD, Istvan Modos, PhD, Matej Roder, MSc, Martina Fialova, MSc, Jana Machkova, MSc, Katerina Kabrtova, MSc, Petra Hruba, PhD, Maria Magicova, MD, Antonij Slavcev, MD, PhD, Ilja Striz, MD, PhD, Ondrej Viklicky, MD, PhD

Get full text

Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss by Vojtech Petr, MD, Petra Hruba, PhD, Marek Kollar, MD, Karel Krejci, MD, PhD, Roman Safranek, MD, PhD, Sona Stepankova, MD, Jarmila Dedochova, MD, Jana Machova, MD, Jakub Zieg, MD, PhD, Janka Slatinska, MD, Eva Pokorna, MD, PhD, Ondrej Viklicky, MD, PhD

Get full text